Omnipaque 350mg/ml Inj, 100ml
Overview
What is this medicine?
How to Use This Medicine
To ensure safe and effective use of this medication, follow your doctor's instructions carefully. Read all the information provided to you and adhere to the instructions closely.
Preparation and Administration
Before receiving this medication, it is essential to be properly hydrated. Consult your doctor to determine if you need to drink extra fluids before administration. After taking this medication, drink plenty of non-caffeinated liquids, unless your doctor advises you to limit your fluid intake.
Administration Methods
Injection: This medication will be administered by your doctor. You may receive other medications before this one to help prevent side effects.
Liquid: This medication can be taken orally or administered rectally.
Storage and Disposal
Liquid: If you need to store this medication at home, consult your doctor, nurse, or pharmacist for guidance on proper storage.
Injection: This medication will be administered in a healthcare setting, and you will not need to store it at home.
Missed Dose
Liquid: If you miss a dose, contact your doctor to determine the best course of action.
Injection: Since this medication is administered in a healthcare setting, you will not need to worry about missing a dose.
Lifestyle & Tips
- Stay well-hydrated before and after the procedure, especially if you have kidney problems or diabetes. Your doctor or nurse will give you specific instructions.
- Inform your healthcare provider about all medications you are taking, especially for diabetes (like metformin) or kidney conditions.
- Report any history of allergies, especially to iodine, shellfish, or previous contrast dyes.
Available Forms & Alternatives
Available Strengths:
- Omnipaque 300mg/ml Inj, 30ml
- Omnipaque 240mg/ml Inj, 50ml
- Omnipaque 350mg/ml Inj, 50ml
- Omnipaque 240mg/ml Inj, 100ml
- Omnipaque 350mg/ml Inj, 500ml
- Omnipaque 300mg/ml Inj, 50ml
- Omnipaque 180mg/ml Inj, 10ml
- Omnipaque 350mg/ml Inj, 200ml
- Omnipaque 350mg/ml Inj, 150ml
- Omnipaque 350mg/ml Inj, 100ml
- Omnipaque 240mg/ml Inj, 20ml
- Omnipaque 240mg/ml Inj, 10ml
- Omnipaque 300mg/ml Inj, 150ml
- Omnipaque 300mg/ml Inj, 100ml
- Omnipaque 300mg/ml Inj, 500ml
- Omnipaque 300mg/ml Inj, 10ml
- Omnipaque 140mg/ml Inj, 50ml
Dosing & Administration
Adult Dosing
Condition-Specific Dosing:
Pediatric Dosing
Dose Adjustments
Renal Impairment:
Hepatic Impairment:
Pharmacology
Mechanism of Action
Pharmacokinetics
Absorption:
Distribution:
Elimination:
Pharmacodynamics
Safety & Warnings
Side Effects
Although rare, some people may experience severe and potentially life-threatening side effects while taking this medication. If you notice any of the following symptoms, contact your doctor or seek medical attention immediately:
Allergic reactions: Rash, hives, itching, red, swollen, blistered, or peeling skin with or without fever, wheezing, tightness in the chest or throat, trouble breathing, swallowing, or talking, unusual hoarseness, or swelling of the mouth, face, lips, tongue, or throat. In rare cases, allergic reactions can be fatal.
Thyroid problems: Changes in weight, feeling nervous, excitable, restless, or weak, hair thinning, depression, eye or neck swelling, difficulty focusing, trouble with heat or cold, menstrual changes, shakiness, or sweating.
Injection-related side effects:
+ Chest pain or pressure, rapid heartbeat, or abnormal heartbeat.
+ Weakness on one side of the body, trouble speaking or thinking, changes in balance, drooping on one side of the face, or blurred vision.
+ Severe dizziness or fainting.
+ Shortness of breath, significant weight gain, or swelling in the arms or legs.
+ Swelling, warmth, numbness, color changes, or pain in a leg or arm.
+ Seizures.
+ Changes in vision.
Tissue damage: If the medication leaks from the vein, it can cause tissue damage. Inform your nurse if you experience redness, burning, pain, swelling, blisters, skin sores, or fluid leakage at the injection site.
Severe skin reactions: These can occur anywhere from 1 hour to several weeks after receiving the medication and may include:
+ Stevens-Johnson syndrome (SJS)
+ Toxic epidermal necrolysis (TEN)
+ Other serious reactions that can affect body organs and be life-threatening.
+ Symptoms may include red, swollen, blistered, or peeling skin; red or irritated eyes; sores in the mouth, throat, nose, eyes, genitals, or skin; fever; chills; body aches; shortness of breath; or swollen glands.
Spinal injection side effects: A burning, numbness, or tingling sensation that is not normal.
Liquid formulation side effects: Swelling.
Other Possible Side Effects
Most people do not experience significant side effects, but some may occur. If you are bothered by any of the following side effects or if they persist, contact your doctor or seek medical attention:
Common side effects:
+ Upset stomach or vomiting
+ Headache
Injection-related side effects (if given in an artery or vein):
+ Dizziness
+ Feeling of warmth
+ Changes in taste
Spinal injection side effects:
+ Dizziness
+ Back pain
+ Neck pain
+ Stiff neck
* Liquid formulation side effects:
+ Stomach pain or diarrhea
+ Gas
This is not an exhaustive list of possible side effects. If you have questions or concerns about side effects, consult your doctor. You can also report side effects to the FDA at 1-800-332-1088 or online at https://www.fda.gov/medwatch.
Seek Immediate Medical Attention If You Experience:
- Difficulty breathing, wheezing, or tightness in the chest
- Hives, rash, or severe itching
- Swelling of the face, lips, tongue, or throat
- Sudden dizziness or feeling faint
- Unusual weakness or tiredness
- Changes in how much you urinate (less than usual)
Before Using This Medicine
It is essential to inform your doctor about the following conditions to ensure safe use of this medication:
Allergies: If you are allergic to this drug, any of its components, or other medications, foods, or substances, notify your doctor. Describe the allergic reaction and its symptoms.
Dehydration and poor nutrition: If you are dehydrated, have been eating poorly, or have recently used a laxative or diuretic, inform your doctor.
Previous skin reactions: If you have experienced a skin reaction to this medication or a similar drug in the past, tell your doctor.
Metformin use: If you are taking metformin, notify your doctor.
Additional Considerations for Specific Administration Routes:
Spinal injection: If you have an infection or are taking medications that may increase the risk of seizures, or have taken such a medication in the last 48 hours, inform your doctor. Many medications can increase seizure risk, so ask your doctor or pharmacist if you are unsure.
Injection into an artery or vein: If you are unable to urinate, notify your doctor.
Use before an x-ray of the uterus and fallopian tubes: If you are menstruating, have a genital infection, or have or may have a growth in the reproductive tract, inform your doctor. Additionally, if you have had a curettage or conization procedure within the past 30 days, or if you have had a pregnancy terminated within the past 6 months, notify your doctor.
Pregnancy and This Medication:
Do not take this medication if you are pregnant or may be pregnant.
Interactions with Other Medications and Health Conditions:
This is not an exhaustive list of all potential interactions. Inform your doctor and pharmacist about all your medications, including prescription and over-the-counter drugs, natural products, and vitamins, as well as any health problems.
It is crucial to verify that it is safe to take this medication with all your other medications and health conditions. Do not start, stop, or change the dose of any medication without consulting your doctor.
Precautions & Cautions
It is essential to inform all your healthcare providers, including doctors, nurses, pharmacists, and dentists, that you are taking this medication. Your doctor may need to monitor your blood work, and this medication may affect certain lab tests. Be sure to notify all your healthcare providers and lab workers that you are taking this drug.
If you experience any signs of kidney problems, such as difficulty urinating, changes in urine output, bloody, brown, or foamy urine, shortness of breath, cough, or swelling in your face, feet, or hands, contact your doctor immediately.
Special Considerations
If you are 65 or older, use this medication with caution, as you may be more susceptible to side effects. Similarly, if the patient is a child, use this medication with caution, as the risk of side effects may be higher in some children.
If you are pregnant, plan to become pregnant, or are breastfeeding, consult your doctor to discuss the benefits and risks of this medication to you and your baby.
Injection (Arterial or Venous Administration)
In children under 3 years of age, the use of medications like this one has been associated with low thyroid function, which can impact child development. If the patient is a child, your doctor may need to monitor their thyroid function for an extended period after the injection.
Rarely, life-threatening or fatal heart problems, including low blood pressure and heart attack, have been reported with this medication. Discuss these risks with your doctor.
Additionally, health problems like blood clots have occurred with this medication when used in conjunction with certain procedures, which can increase the risk of heart attack and stroke. If you have questions, consult your doctor.
Injection (Intraspinal Administration)
This medication may increase the risk of seizures in some individuals, particularly those with a history of seizures. Consult your doctor to determine if you are at a higher risk of seizures while taking this medication.
Overdose Information
Overdose Symptoms:
- Severe hypotension (low blood pressure)
- Fluid overload (pulmonary edema)
- Acute renal failure
- Seizures (especially with intrathecal overdose)
What to Do:
Treatment is symptomatic and supportive. Maintain airway, breathing, and circulation. Administer IV fluids for hypotension. Hemodialysis can remove Iohexol from the body. Call 1-800-222-1222 (Poison Control) or seek immediate medical attention.
Drug Interactions
Major Interactions
- Metformin (in patients with renal impairment or acute kidney injury)
- Interleukin-2 (IL-2) (increased risk of delayed adverse reactions)
Moderate Interactions
- Beta-blockers (increased risk of anaphylactoid reactions, blunted response to epinephrine)
- Diuretics (increased risk of dehydration and contrast-induced nephropathy)
- Nephrotoxic drugs (e.g., NSAIDs, aminoglycosides, cisplatin) (increased risk of renal impairment)
- Oral cholecystographic agents (may impair visualization)
Monitoring
Baseline Monitoring
Rationale: To assess baseline kidney function and risk of contrast-induced nephropathy (CIN).
Timing: Within 30 days prior to contrast administration, ideally within 7 days for high-risk patients.
Rationale: To identify patients at increased risk for hypersensitivity reactions.
Timing: Prior to administration.
Rationale: To identify patients at risk for contrast-induced hyperthyroidism, especially in those with pre-existing thyroid disease.
Timing: Consider in patients with known or suspected thyroid dysfunction.
Rationale: Adequate hydration is crucial for preventing CIN.
Timing: Prior to administration.
Routine Monitoring
Frequency: Before, during, and immediately after injection, then as clinically indicated.
Target: Within patient's normal limits.
Action Threshold: Significant deviations (e.g., hypotension, bradycardia, desaturation) require immediate intervention.
Frequency: Continuously during and for at least 30 minutes post-injection.
Target: Absence of symptoms.
Action Threshold: Rash, urticaria, dyspnea, bronchospasm, angioedema, hypotension.
Frequency: 24-72 hours post-contrast in high-risk patients (e.g., pre-existing renal impairment, diabetes, dehydration).
Target: Stable or returning to baseline.
Action Threshold: Increase in serum creatinine by âĨ 0.3 mg/dL or âĨ 50% from baseline within 48-72 hours.
Symptom Monitoring
- Hives
- Itching
- Rash
- Swelling of face, lips, tongue, or throat
- Difficulty breathing or wheezing
- Dizziness or lightheadedness
- Nausea
- Vomiting
- Headache
- Flushing
- Chest pain
- Abdominal pain
- Changes in urine output (decreased)
Special Patient Groups
Pregnancy
Iohexol is classified as Pregnancy Category B. Animal studies have not shown harm to the fetus, but there are no adequate and well-controlled studies in pregnant women. Use only if clearly needed and the potential benefit outweighs the potential risk to the fetus. Minimize fetal exposure by using the lowest effective dose.
Trimester-Specific Risks:
Lactation
Iohexol is excreted into breast milk in very small amounts (less than 0.5% of the administered dose). The amount absorbed by the infant is negligible. The American College of Radiology (ACR) and European Society of Urogenital Radiology (ESUR) state that breastfeeding can continue without interruption after administration of iodinated contrast media. If concerns exist, a temporary interruption of breastfeeding for 12-24 hours can be considered, but is generally not necessary.
Pediatric Use
Dosing must be carefully calculated based on weight and procedure. Children, especially neonates and infants, are more susceptible to fluid shifts and temperature changes. Use the lowest effective dose and ensure adequate hydration. Risk of thyroid dysfunction (hypothyroidism) in neonates and infants is a concern, especially in premature infants or those with underlying thyroid conditions; monitoring of thyroid function may be warranted.
Geriatric Use
Elderly patients are more likely to have impaired renal function, cardiovascular disease, and diabetes, increasing their risk for contrast-induced nephropathy and other adverse reactions. Careful assessment of renal function and hydration status is crucial. Use the lowest effective dose and ensure adequate hydration. Monitor closely for adverse effects.
Clinical Information
Clinical Pearls
- Always assess renal function (eGFR) before administering iodinated contrast, especially in patients with risk factors for CIN (e.g., pre-existing renal impairment, diabetes, dehydration, heart failure).
- Ensure adequate hydration before and after contrast administration, particularly in high-risk patients. Isotonic saline is generally preferred for prophylaxis against CIN.
- Patients on metformin should have it withheld at the time of or prior to the procedure and for 48 hours afterward, and restarted only after renal function has been re-evaluated and found to be normal, to prevent lactic acidosis.
- Be prepared for hypersensitivity reactions, ranging from mild (urticaria) to severe (anaphylaxis). Have emergency equipment and medications (epinephrine, antihistamines, corticosteroids) readily available.
- For patients with a history of previous contrast reactions, premedication with corticosteroids and antihistamines may be considered, though it does not guarantee prevention of a reaction.
- Iohexol is a non-ionic contrast agent, which generally has a lower incidence of adverse reactions compared to older ionic agents due to lower osmolality.
Alternative Therapies
- Iopamidol (Isovue)
- Ioversol (Optiray)
- Iodixanol (Visipaque - iso-osmolar contrast agent, potentially lower risk of CIN in high-risk patients)
- Gadolinium-based contrast agents (for MRI, different mechanism, different risks)
- Non-contrast imaging modalities (e.g., ultrasound, non-contrast CT, non-contrast MRI) when appropriate.